Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4670

1.

The Speckle Tracking Imaging for the Assessment of Cardiac Resynchronization Therapy (START) study.

Maruo T, Seo Y, Yamada S, Arita T, Ishizu T, Shiga T, Dohi K, Toide H, Furugen A, Inoue K, Daimon M, Kawai H, Tsuruta H, Nishigami K, Yuda S, Ozawa T, Izumi C, Fumikura Y, Wada Y, Doi M, Okada M, Takenaka K, Aonuma K.

Circ J. 2015;79(3):613-22. doi: 10.1253/circj.CJ-14-0842. Epub 2014 Dec 27.

2.

Predominant role of neural arc in sympathetic baroreflex resetting of spontaneously hypertensive rats.

Sata Y, Kawada T, Shimizu S, Kamiya A, Akiyama T, Sugimachi M.

Circ J. 2015;79(3):592-9. doi: 10.1253/circj.CJ-14-1013. Epub 2014 Dec 27.

3.

Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device.

Imamura T, Kinugawa K, Nitta D, Fujino T, Inaba T, Maki H, Hatano M, Kinoshita O, Nawata K, Kyo S, Ono M.

Circ J. 2015;79(3):560-6. doi: 10.1253/circj.CJ-14-1058. Epub 2014 Dec 25.

4.

Myocardial blood flow in patients with transposition of the great arteries – risk factor for dysfunction of the morphologic systemic right ventricle late after atrial repair.

Hauser M, Meierhofer C, Schwaiger M, Vogt M, Kaemmerer H, Kuehn A.

Circ J. 2015;79(2):425-31. doi: 10.1253/circj.CJ-14-0716. Epub 2014 Dec 19.

5.

Clinical assessment of hypoperfusion in acute heart failure – evergreen or antique?

Frea S, Pidello S, Canavosio FG, Bovolo V, Botta M, Bergerone S, Gaita F.

Circ J. 2015;79(2):398-405. doi: 10.1253/circj.CJ-14-1052. Epub 2014 Dec 19.

6.

Is anticoagulant therapy unnecessary for lower-risk Japanese patients with atrial fibrillation? Lessons from the SAMURAI-NVAF and BAT studies.

Toyoda K.

Circ J. 2015;79(2):307-9. doi: 10.1253/circj.CJ-14-1350. Epub 2014 Dec 24. No abstract available.

7.

Perspectives on catheter ablation of atrial fibrillation.

Takahashi Y.

Circ J. 2015;79(2):305-6. doi: 10.1253/circj.CJ-14-1363. Epub 2014 Dec 27. No abstract available.

8.

Plasma microRNA-100 as a biomarker of coronary plaque vulnerability – a new generation of biomarker for developing acute coronary syndrome.

Izawa H, Amano T.

Circ J. 2015;79(2):303-4. doi: 10.1253/circj.CJ-14-1295. Epub 2014 Dec 18. No abstract available.

9.

Computed tomography-based fractional flow reserve (FFR-CT) – an attractive concept, but still lacking proof of clinical utility.

Schoenhagen P, Desai MY.

Circ J. 2015;79(2):300-2. doi: 10.1253/circj.CJ-14-1306. Epub 2014 Dec 24. No abstract available.

10.

Renal angioplasty for atherosclerotic renal artery stenosis revisited – efficacy and safety of renal artery stenting in the J-RAS study.

Mukoyama M, Nakayama Y, Adachi M.

Circ J. 2015;79(2):295-6. doi: 10.1253/circj.CJ-14-1361. Epub 2014 Dec 27. No abstract available.

11.

How can we bridge the results of global clinical trials and region/country specific clinical practice by region/country specific registry data?

Goto S, Goto S.

Circ J. 2015;79(2):287-8. doi: 10.1253/circj.CJ-14-1319. Epub 2014 Dec 24. No abstract available.

12.

Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.

Ichikawa M, Takei Y, Hamasaki T, Kijima Y.

Circ J. 2015;79(1):85-90. doi: 10.1253/circj.CJ-14-0639. Epub 2014 Oct 30.

13.

Clinical utility and significance of intravascular ultrasound and optical coherence tomography in guiding percutaneous coronary interventions.

Hibi K, Kimura K, Umemura S.

Circ J. 2015;79(1):24-33. doi: 10.1253/circj.CJ-14-1044. Epub 2014 Dec 19. Review.

14.

Coronary flow reserve estimated by positron emission tomography to diagnose significant coronary artery disease and predict cardiac events.

Naya M, Tamaki N, Tsutsui H.

Circ J. 2015;79(1):15-23. doi: 10.1253/circj.CJ-14-1060. Epub 2014 Dec 18. Review.

15.

The Circulation Journal in the world.

Shimokawa H.

Circ J. 2015;79(1):1-3. doi: 10.1253/circj.CJ-66-0100. Epub 2014 Dec 19. No abstract available.

16.

Plasma microRNA-100 is associated with coronary plaque vulnerability.

Soeki T, Yamaguchi K, Niki T, Uematsu E, Bando S, Matsuura T, Ise T, Kusunose K, Hotchi J, Tobiume T, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Shimabukuro M, Sata M.

Circ J. 2015;79(2):413-8. doi: 10.1253/circj.CJ-14-0958. Epub 2014 Dec 17.

17.

Report of the American Heart Association (AHA) Scientific Sessions 2014, Chicago.

Kohno T.

Circ J. 2015;79(1):34-40. doi: 10.1253/circj.CJ-14-1329. Epub 2014 Dec 15.

18.

Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial.

Karjalainen PP, Varho V, Nammas W, Mikkelsson J, Pietilä M, Ylitalo A, Airaksinen JK, Sia J, Nyman K, Biancari F, Kiviniemi T.

Circ J. 2015;79(2):360-7. doi: 10.1253/circj.CJ-14-1000. Epub 2014 Dec 15.

19.

Concomitant septal myectomy in patients undergoing aortic valve replacement for severe aortic stenosis.

Lim JY, Choi JO, Oh JK, Li Z, Park SJ.

Circ J. 2015;79(2):375-80. doi: 10.1253/circj.CJ-14-0672. Epub 2014 Dec 15.

20.

Unraveling new therapeutic targets of coronary artery disease by genetic approaches.

Lee SE, Kim HS.

Circ J. 2015;79(1):8-14. doi: 10.1253/circj.CJ-14-0985. Epub 2014 Dec 12. Review.

Supplemental Content

Loading ...
Support Center